Cognitive Recovery After Stroke: Memory

被引:11
|
作者
O'Sullivan, Michael J. [1 ,2 ,3 ]
Li, Xuqian [2 ]
Galligan, Dana [2 ]
Pendlebury, Sarah T. [4 ,5 ,6 ,7 ]
机构
[1] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia
[2] Univ Queensland, Fac Med, UO Ctr Clin Res, Herston, Qld, Australia
[3] Royal Brisbane & Womens Hosp, Dept Neurol, Brisbane, Qld, Australia
[4] Univ Oxford, Nuffield Dept Clin Neurosci, Wolfson Ctr Prevent Stroke & Dementia, Oxford, England
[5] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Dept Med, Oxford, England
[6] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Dept Geratol, Oxford, England
[7] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, UK Natl Inst Hlth & Care, Oxford Biomed Res Ctr, Oxford, England
关键词
biomarkers; cognition; dementia; memory; prognosis; IMPAIRMENT HARMONIZATION STANDARDS; TRANSIENT ISCHEMIC ATTACK; MEDIAL TEMPORAL-LOBE; RISK-FACTORS; NEUROLOGICAL DISORDERS; NATIONAL INSTITUTE; EPISODIC MEMORY; CANADIAN STROKE; POSTSTROKE; DECLINE;
D O I
10.1161/STROKEAHA.122.041497
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Memory impairment occurs in over a third of patients after symptomatic stroke. Memory deficits rarely occur in isolation but are an important component of the poststroke cognitive syndrome because of the strong relationship with the risk of poststroke dementia. In this review, we summarize available data on impairment of episodic memory, with a particular emphasis on the natural history of memory impairment after stroke and the factors influencing trajectory informed by an updated systematic review. We next discuss the pathophysiology of memory impairment and mechanisms of both decline and recovery of function. We then turn to the practical issue of measurement of memory deficits after stroke, emerging biomarkers, and therapeutic approaches. Our review identifies critical gaps, particularly in studies of the natural history that properly map the long-term trajectory of memory and the associations with factors that modulate prognosis. Few studies have used advanced neuroimaging and this, in conjunction with other biomarker approaches, has the potential to provide a much richer understanding of the mechanisms at play and promising therapeutic avenues.
引用
收藏
页码:44 / 54
页数:11
相关论文
共 50 条
  • [41] Fluoxetine and recovery after stroke
    van der Worp, H. Bart
    LANCET, 2019, 393 (10168): : 206 - 207
  • [42] Pharmacology of recovery after stroke
    Goldstein, LB
    NEUROLOGICAL REHABILITATION, PROCEEDINGS, 2002, : 7 - 12
  • [43] Functional recovery after stroke
    Ezzie Hutchinson
    Nature Reviews Neuroscience, 2011, 12 (1) : 4 - 4
  • [44] EARLY RECOVERY AFTER STROKE
    WADE, DT
    HEWER, RL
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1985, 48 (06): : 601 - 601
  • [45] Biomarkers of recovery after stroke
    Milot, Marie-Helene
    Cramer, Steven C.
    CURRENT OPINION IN NEUROLOGY, 2008, 21 (06) : 654 - 659
  • [46] Levodopa and recovery after stroke
    Vinzio, S
    Goichot, B
    LANCET, 2002, 359 (9304): : 443 - 444
  • [47] RECOVERY OF FUNCTION AFTER STROKE
    WADE, DT
    WOOD, VA
    HEWER, RL
    INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH, 1985, 8 (02) : 247 - 247
  • [48] Recovery and Rehabilitation after Stroke
    Brown, Allen W.
    Schultz, Billie A.
    SEMINARS IN NEUROLOGY, 2010, 30 (05) : 511 - 517
  • [49] Pharmacology of recovery after stroke
    Dam, M
    Piron, L
    Casson, S
    Sale, E
    Iaia, V
    Piccione, F
    Meneghello, F
    Tonin, P
    5TH CONGRESS OF THE EUROPEAN SOCIETY FOR CLINICAL NEUROPHARMACOLOGY, 2000, : 175 - 182
  • [50] Plasticity and recovery after stroke
    Ward, N
    PROCEEDINGS OF THE 7TH CONGRESS OF THE EUROPEAN SOCIETY FOR CLINICAL NEUROPHARMACOLOGY, 2004, : 27 - 32